Robert V. Emmons, M.D., FACP

Robert Emmons

Robert V. Emmons, M.D., FACP

  • Associate Professor of Medicine

UofL Health - James Graham Brown Cancer Center
529 South Jackson Street
Louisville, KY 40202
502-562-3367 - Academic Office
502-562-4543 - Patient Appointments

Clinical Expertise
Blood and Bone Marrow Transplantation; Hematology

Board Certifications

  • American Board of Internal Medicine -
    Internal Medicine / Hematology

Education and Training

  • Medical School: University of Cincinnati College of Medicine
  • Residency: University of Michigan Affiliated Hospitals
  • Fellowship: National Institutes of Health

Featured Publications

  • Lonial S, Jacobus S, Fonseca R, Weiss M, Kumar S, Orlowski RZ, Kaufman JL, Yacoub AM, Buadi FK, O'Brien T, Matous JV, Anderson DM, Emmons RV, Mahindra A, Wagner LI, Dhodapkar MV, Rajkumar SV. Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma. J Clin Oncol. 2019 Oct 25:JCO1901740. doi: 10.1200/JCO.19.01740. [Epub ahead of print] PubMed PMID: 31652094.
  • Hashmi H, Dhanoa JS, Emmons R. Rare case of Bing-Neel syndrome treated successfully with ibrutinib. BMJ Case Rep. 2019 Jun 25;12(6). pii: e230067. doi: 10.1136/bcr-2019-230067. PubMed PMID: 31243026.
  • Fidler C, Klumpp T, Mangan K, Martin M, Sharma M, Emmons R, Lu M, Kropf P. Spontaneous graft versus host disease occurring in a patient with multiple myeloma after autologous stem cell transplant. Am J Hematol. 2012 Feb;87(2):219-21. doi: 10.1002/ajh.22227. Epub 2011 Dec 21. PubMed PMID: 22189875.
  • Jordan WE 3rd, Emmons R, Vogl D, Morris GJ. Monoclonal gammopathy of undetermined significance versus smoldering myeloma: is active surveillance enough? Semin Oncol. 2011 Jun;38(3):327-34. doi: 10.1053/j.seminoncol.2011.03.019. PubMed PMID: 21600358.
  • Emmons R, Morris GJ. Readers' responses to "Cancer of unknown primary site: advances in diagnostics". Semin Oncol. 2010 Dec;37(6):555. doi: 10.1053/j.seminoncol.2010.10.021. PubMed PMID: 21167373.
  • Shanbhag S, Smith MR, Emmons RV. Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation. Stem Cells Cloning. 2010 Jul 7;3:93-102. Review. PubMed PMID: 24198514; PubMed Central PMCID: PMC3781733.
  • Witkiewicz AK, McConnell T, Potoczek M, Emmons RV, Kurman RJ. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Hum Pathol. 2010 Jan;41(1):26-32. doi: 10.1016/j.humpath.2009.06.012. Epub 2009 Sep 4. PubMed PMID: 19733383.
  • Wu KN, Emmons RV, Lisanti MP, Farber JL, Witkiewicz AK. Foxp3-expressing T regulatory cells and mast cells in acute graft-versus-host disease of the skin. Cell Cycle. 2009 Nov 1;8(21):3601-5. Epub 2009 Nov 4. PubMed PMID: 19838066.
  • Brody JR, Costantino CL, Berger AC, Sato T, Lisanti MP, Yeo CJ, Emmons RV, Witkiewicz AK. Expression of indoleamine 2,3-dioxygenase in metastatic malignant melanoma recruits regulatory T cells to avoid immune detection and affects survival. Cell Cycle. 2009 Jun 15;8(12):1930-4. Epub 2009 Jun 15. PubMed PMID: 19448397.
  • Wirk B, Klumpp TR, Ulicny J, Herman JH, Gajewski JL, Martin ME, Emmons RV, Mangan KF. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation. Transfusion. 2008 Jan;48(1):163-8. Epub 2007 Sep 27. PubMed PMID: 17900280.